Ministry of Health ServicesGoverment of British Columbia
Pharmacare Program
| Home | SA Criteria | SA Forms | RDP | LCA |
Limited Coverage Drugs - Special Authority Criteria

Generic Name / Strength / Form
interferon alfa

Criteria Approval Period
1. Diagnosis of chronic Hepatitis B, non-cirrhosis. According to established protocols; lab work required.

Submit Hepatitis B requests using the Chronic Hepatitis B form. See form link below.

1. First approval: 24 weeks

One Renewal: Up to 24 weeks, only if patient demonstrates a positive response to treatment.

OR

2. Treatment of chronic Hepatitis C according to established protocols (similar eligibility criteria as for interferon / ribavirin combination therapy).

Submit Hepatitis C requests on the Pegylated Interferon/Ribavirin Coverage form. See form link below. Please clearly indicate coverage request is for interferon.

2. First approval: Sixteen weeks

Renewals: Thirty-six weeks, only if patient demonstrates a positive response to treatment, defined as a negative PCR.

Practitioner Exemptions

  • No practitioner exemptions

Special Notes

  • None

Forms

Chronic Hepatitis B - Initial and Renewal Coverage (PDF)
Click on the link to complete a special authority request form.

Pegylated Interferon/Ribavirin Coverage (PDF)
Click on the link to complete a special authority request form.



PDF Format

Some documents on this Web site are in PDF format and require a PDF reader. If you do not have Adobe Acrobat Reader Version 7.0 or the most recent version of another PDF reader, you can download Adobe Acrobat Reader by selecting the 'Get Acrobat Reader' icon. Get Acrobat Reader Icon

Back To Top

Last Revised: March 20, 2008

blank
    space for alignment
Go to TopGo to CopyrightGo to DisclaimerGo to Privacy StatementGo to Feedback Form
blank space for alignment blank space for alignment blank
    space for alignment blank space for alignment blank space for alignment blank space for alignment